MYC‐amplified cells were sensitive to Aurora kinase inhibitor in SCLC models; however MYCL and MYCN showed very slight response (Bragelmann et al., 2017; Mollaoglu et al., 2017). Here, MYCN is linked to small cell lung carcinoma.